Status epilepticus in adults

The Lancet Neurology

Volumn 14, Issue 6, 2015, Pages 615-624

  Betjemann, John P ^a   Lowenstein, Daniel H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT;

ADULT DISEASE; BRAIN RADIOGRAPHY; CLINICAL FEATURE; CLINICAL RESEARCH; DIAGNOSTIC VALUE; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; HOSPITAL MANAGEMENT; HUMAN; NERVE CELL LESION; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PNEUMOENCEPHALOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFRACTORY STATUS EPILEPTICUS; REVIEW; ADULT; STATUS EPILEPTICUS;

ADULT; ANTICONVULSANTS; HUMANS; STATUS EPILEPTICUS;

EID: 84929503098     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(15)00042-3     Document Type: Review

References (117)

1. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996, 46:1029-1035.
2. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 1998, 50:735-741.
3. Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA Time trends in incidence, mortality, and case-fatality after first episode of status epilepticus. Epilepsia 2001, 42:1031-1035.
4. Knake S, Rosenow F, Vescovi M, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001, 42:714-718.
5. Coeytaux A, Jallon P, Galobardes B, Morabia A Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 2000, 55:693-697.
6. Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA Short-term mortality after a first episode of status epilepticus. Epilepsia 1997, 38:1344-1349.
7. Logroscino G, Hesdorffer DC, Cascino G, et al. Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia 2005, 46(suppl 11):46-48.
8. Strzelczyk A, Knake S, Oertel WH, Rosenow F, Hamer HM Inpatient treatment costs of status epilepticus in adults in Germany. Seizure 2013, 22:882-885.
9. Penberthy LT, Towne A, Garnett LK, Perlin JB, DeLorenzo RJ Estimating the economic burden of status epilepticus to the health care system. Seizure 2005, 14:46-51.
10. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981, 22:489-501. Proposal for revised clinical and electroencephalographic classification of epileptic seizures.
11. Treatment of convulsive status epilepticus. JAMA 1993, 270:854-859. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus.
12. Jenssen S, Gracely EJ, Sperling MR How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia 2006, 47:1499-1503.
13. A receptors. J Neurosci 1997, 17:7532-7540.
14. Jones DM, Esmaeil N, Maren S, Macdonald RL Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res 2002, 50:301-312.
15. Lowenstein DH, Bleck T, Macdonald RL It's time to revise the definition of status epilepticus. Epilepsia 1999, 40:120-122.
16. Hauser WA Status epilepticus: epidemiologic considerations. Neurology 1990, 40(suppl 2):9-13.
17. Vignatelli L, Tonon C, D'Alessandro R Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 2003, 44:964-968. the Bologna Group for the Study of Status Epilepticus.
18. Dham BS, Hunter K, Rincon F The epidemiology of status epilepticus in the United States. Neurocrit Care 2014, 20:476-483.
19. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol 1998, 44:908-912.
20. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG Epidemiology of status epilepticus. J Clin Neurophysiol 1995, 12:316-325.
21. DeLorenzo RJ, Garnett LK, Towne AR, et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia 1999, 40:164-169.
22. Towne AR, Pellock JM, Ko D, DeLorenzo RJ Determinants of mortality in status epilepticus. Epilepsia 1994, 35:27-34.
23. Wu YW, Shek DW, Garcia PA, Zhao S, Johnston SC Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 2002, 58:1070-1076.
24. Rossetti AO, Logroscino G, Bromfield EB A clinical score for prognosis of status epilepticus in adults. Neurology 2006, 66:1736-1738.
25. Sutter R, Kaplan PW, Rüegg S Independent external validation of the status epilepticus severity score. Crit Care Med 2013, 41:e475-e479.
26. Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol 2008, 255:1561-1566.
27. Perl TM, Bédard L, Kosatsky T, Hockin JC, Todd EC, Remis RS An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid. N Engl J Med 1990, 322:1775-1780.
28. Teitelbaum JS, Zatorre RJ, Carpenter S, et al. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med 1990, 322:1781-1787.
29. Chen JW, Naylor DE, Wasterlain CG Advances in the pathophysiology of status epilepticus. Acta Neurol Scand Suppl 2007, 186:7-15.
30. Naylor DE, Liu H, Wasterlain CG Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci 2005, 25:7724-7733.
31. Goodkin HP, Sun C, Yeh JL, Mangan PS, Kapur J GABA(A) receptor internalization during seizures. Epilepsia 2007, 48(suppl 5):109-113.
32. Naylor DE, Liu H, Niquet J, Wasterlain CG Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus. Neurobiol Dis 2013, 54:225-238.
33. Liu H, Mazarati AM, Katsumori H, Sankar R, Wasterlain CG Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus. Proc Natl Acad Sci USA 1999, 96:5286-5291.
34. Lado FA, Moshé SL How do seizures stop?. Epilepsia 2008, 49:1651-1664.
35. Elliott RC, Miles MF, Lowenstein DH Overlapping microarray profiles of dentate gyrus gene expression during development- and epilepsy-associated neurogenesis and axon outgrowth. J Neurosci 2003, 23:2218-2227.
36. Roopra A, Dingledine R, Hsieh J Epigenetics and epilepsy. Epilepsia 2012, 53(suppl 9):2-10.
37. Miller-Delaney SFC, Das S, Sano T, et al. Differential DNA methylation patterns define status epilepticus and epileptic tolerance. J Neurosci 2012, 32:1577-1588.
38. Jimenez-Mateos EM, Henshall DC Epilepsy and microRNA. Neuroscience 2013, 238:218-229.
39. Meldrum BS, Horton RW Physiology of status epilepticus in primates. Arch Neurol 1973, 28:1-9.
40. Meldrum BS, Vigouroux RA, Brierley JB Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol 1973, 29:82-87.
41. Sloviter RS Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 1987, 235:73-76.
42. Sankar R, Shin DH, Liu H, Mazarati A, Pereira de Vasconcelos A, Wasterlain CG Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. J Neurosci 1998, 18:8382-8393.
43. Chuang YC, Chang AYW, Lin J-W, Hsu S-P, Chan SHH Mitochondrial dysfunction and ultrastructural damage in the hippocampus during kainic acid-induced status epilepticus in the rat. Epilepsia 2004, 45:1202-1209.
44. Lopez-Meraz M-L, Niquet J, Wasterlain CG Distinct caspase pathways mediate necrosis and apoptosis in subpopulations of hippocampal neurons after status epilepticus. Epilepsia 2010, 51(suppl 3):56-60.
45. Rabinowicz AL, Correale JD, Bracht KA, Smith TD, DeGiorgio CM Neuron-specific enolase is increased after nonconvulsive status epilepticus. Epilepsia 1995, 36:475-479.
46. DeGiorgio CM, Correale JD, Gott PS, et al. Serum neuron-specific enolase in human status epilepticus. Neurology 1995, 45:1134-1137.
47. DeGiorgio CM, Gott PS, Rabinowicz AL, Heck CN, Smith TD, Correale JD Neuron-specific enolase, a marker of acute neuronal injury, is increased in complex partial status epilepticus. Epilepsia 1996, 37:606-609.
48. Meierkord H, Holtkamp M Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol 2007, 6:329-339.
49. Lowenstein DH, Aminoff MJ Clinical and EEG features of status epilepticus in comatose patients. Neurology 1992, 42:100-104.
50. Simon RP, Aminoff MJ Electrographic status epilepticus in fatal anoxic coma. Ann Neurol 1986, 20:351-355.
51. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998, 39:833-840.
52. Claassen J, Hirsch LJ, Frontera JA, et al. Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care 2006, 4:103-112.
53. Sung C-Y, Chu N-S Epileptic seizures in intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 1989, 52:1273-1276.
54. Bateman BT, Claassen J, Willey JZ, et al. Convulsive status epilepticus after ischemic stroke and intracerebral hemorrhage: frequency, predictors, and impact on outcome in a large administrative dataset. Neurocrit Care 2007, 7:187-193.
55. De Reuck J, Hemelsoet D, Van Maele G Seizures and epilepsy in patients with a spontaneous intracerebral haematoma. Clin Neurol Neurosurg 2007, 109:501-504.
56. Labovitz DL, Hauser WA, Sacco RL Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology 2001, 57:200-206.
57. Velioğlu SK, Ozmenoğlu M, Boz C, Alioğlu Z Status epilepticus after stroke. Stroke 2001, 32:1169-1172.
58. Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990, 323:497-502.
59. Vespa PM, Miller C, McArthur D, et al. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med 2007, 35:2830-2836.
60. Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000, 54:340-345.
61. Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004, 62:1743-1748.
62. Oddo M, Carrera E, Claassen J, Mayer SA, Hirsch LJ Continuous electroencephalography in the medical intensive care unit. Crit Care Med 2009, 37:2051-2056.
63. Kamel H, Betjemann JP, Navi BB, et al. Diagnostic yield of electroencephalography in the medical and surgical intensive care unit. Neurocrit Care 2012, 19:336-341.
64. Betjemann JP, Nguyen I, Santos-Sanchez C, Douglas VC, Josephson SA Diagnostic yield of electroencephalography in a general inpatient population. Mayo Clin Proc 2013, 88:326-331.
65. Kurtz P, Gaspard N, Wahl AS, et al. Continuous electroencephalography in a surgical intensive care unit. Intensive Care Med 2014, 40:228-234.
66. Young GB, Jordan KG, Doig GS An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology 1996, 47:83-89.
67. Dennis LJ, Claassen J, Hirsch LJ, Emerson RG, Connolly ES, Mayer SA Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurgery 2002, 51:1136-1143.
68. Aicardi J, Amsili J, Chevrie JJ Acute hemiplegia in infancy and childhood. Dev Med Child Neurol 1969, 11:162-173.
69. Kramer RE, Lüders H, Lesser RP, et al. Transient focal abnormalities of neuroimaging studies during focal status epilepticus. Epilepsia 1987, 28:528-532.
70. Lansberg MG, O'Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW MRI abnormalities associated with partial status epilepticus. Neurology 1999, 52:1021-1027.
71. Boyd JG, Taylor S, Rossiter JP, Islam O, Spiller A, Brunet DG New-onset refractory status epilepticus with restricted DWI and neuronophagia in the pulvinar. Neurology 2010, 74:1003-1005.
72. Shinnar S, Bello JA, Chan S, et al. MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study. Neurology 2012, 79:871-877.
73. Cianfoni A, Caulo M, Cerase A, et al. Seizure-induced brain lesions: a wide spectrum of variably reversible MRI abnormalities. Eur J Radiol 2013, 82:1964-1972.
74. Cartagena AM, Young GB, Lee DH, Mirsattari SM Reversible and irreversible cranial MRI findings associated with status epilepticus. Epilepsy Behav 2014, 33:24-30.
75. Massaro AM Teaching neuroimages:crossed cerebellar diaschisis in hemispheric status epilepticus. Neurology 2012, 79:e182.
76. Samaniego EA, Stuckert E, Fischbein N, Wijman CA Crossed cerebellar diaschisis in status epilepticus. Neurocrit Care 2010, 12:88-90.
77. Bauer G, Gotwald T, Dobesberger J, et al. Transient and permanent magnetic resonance imaging abnormalities after complex partial status epilepticus. Epilepsy Behav 2006, 8:666-671.
78. Lewis DV, Shinnar S, Hesdorffer DC, et al. Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study. Ann Neurol 2014, 75:178-185. the FEBSTAT Study Team.
79. Lowenstein DH, Alldredge BK Status epilepticus at an urban public hospital in the 1980s. Neurology 1993, 43:483-488.
80. Knudsen FU Rectal administration of diazepam in solution in the acute treatment of convulsions in infants and children. Arch Dis Child 1979, 54:855-857.
81. Hoppu K, Santavuori P Diazepam rectal solution for home treatment of acute seizures in children. Acta Paediatr Scand 1981, 70:369-372.
82. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001, 345:631-637.
83. Scott RC, Besag FM, Neville BG Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet 1999, 353:623-626.
84. McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 2005, 366:205-210.
85. Lahat E, Goldman M, Barr J, Bistritzer T, Berkovitch M Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ 2000, 321:83-86.
86. Nakken KO, Lossius MI Buccal midazolam or rectal diazepam for treatment of residential adult patients with serial seizures or status epilepticus. Acta Neurol Scand 2011, 124:99-103.
87. Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012, 366:591-600.
88. Sechi G, Serra A Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 2007, 6:442-455.
89. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 1998, 339:792-798.
90. Browne TR, Kugler AR, Eldon MA Pharmacology and pharmacokinetics of fosphenytoin. Neurology 1996, 46(suppl 1):S3-S7.
91. Osorio I, Reed RC Treatment of refractory generalized tonic-clonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin. Epilepsia 1989, 30:464-471.
92. Shaner DM, McCurdy SA, Herring MO, Gabor AJ Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 1988, 38:202-207.
93. Misra UK, Kalita J, Patel R Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 2006, 67:340-342.
94. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007, 16:527-532.
95. Gilad R, Izkovitz N, Dabby R, et al. Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin. Acta Neurol Scand 2008, 118:296-300.
96. Alvarez V, Januel J-M, Burnand B, Rossetti AO Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia 2011, 52:1292-1296.
97. Misra UK, Kalita J, Maurya PK Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. J Neurol 2012, 259:645-648.
98. Kellinghaus C, Berning S, Immisch I, et al. Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand 2011, 123:137-141.
99. Höfler J, Unterberger I, Dobesberger J, Kuchukhidze G, Walser G, Trinka E Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia 2011, 52:e148-e152.
100. Yasiry Z, Shorvon SD The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure 2014, 23:167-174.
101. Cock HR Established status epilepticus treatment trial (ESETT). Epilepsia 2011, 52(suppl 8):50-52. the ESETT Group.
102. Riviello JJ, Claassen J, LaRoche SM, et al. Treatment of status epilepticus: an international survey of experts. Neurocrit Care 2013, 18:193-200.
103. Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010, 17:348-355.
104. Ferguson M, Bianchi MT, Sutter R, et al. Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus. Neurocrit Care 2013, 18:216-227.
105. Rossetti AO, Lowenstein DH Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 2011, 10:922-930.
106. Ferlisi M, Shorvon S The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 2012, 135:2314-2328.
107. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons B-F Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002, 59:205-210.
108. Holtkamp M, Othman J, Buchheim K, Meierkord H Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005, 76:534-539.
109. Novy J, Logroscino G, Rossetti AO Refractory status epilepticus: a prospective observational study. Epilepsia 2010, 51:251-256.
110. Rossetti AO, Logroscino G, Bromfield EB Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 2005, 62:1698-1702.
111. Claassen J, Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology 2001, 57:1036-1042.
112. Vasile B, Rasulo F, Candiani A, Latronico N The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003, 29:1417-1425.
113. Claassen J, Hirsch LJ, Emerson RG, Mayer SA Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002, 43:146-153.
114. Rossetti AO, Milligan TA, Vulliémoz S, Michaelides C, Bertschi M, Lee JW A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2011, 14:4-10.
115. Sutter R, Marsch S, Fuhr P, Kaplan PW, Rüegg S Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology 2014, 82:656-664.
116. Kowalski RG, Ziai WC, Rees RN, et al. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med 2012, 40:2677-2684.
117. Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012, 17:3-23.